NCT07013890View on ClinicalTrials.gov

Efficacy of Phycocyanin and Palmitoylethanolamide for the Treatment of Chronic Prostatitis Symptoms

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 2, 2022

Primary Completion Date

August 15, 2023

Study Completion Date

September 30, 2023

Conditions
Chronic Prostatitis (CP)Chronic Prostatitis With Chronic Pelvic Pain SyndromeChronic Prostatitis/ Pelvic Pain Syndrome
Interventions
DRUG

FICOXPEA® is an oral combination of Phycocyanin, Palmitoylethanolamide and selenium

"FICOXPEA® is a phytoterapic compound made of:~* phycocyanin (spirulina platensis extract) 250 mg~* palmitoylethanolamide 200 mg~* L-selenometionine 11 mg"

Trial Locations (2)

10126

Molinette Hospital, Torino

Unknown

Dipartimento di Chirurgia Università di Catania, Catania

All Listed Sponsors
collaborator

A.O.U. Città della Salute e della Scienza - Molinette Hospital

OTHER

lead

Clinica Urologica Molinette - Città della Saliute e della Scienza

OTHER